Ani pharmaceuticals reports q3 eps non-gaap $1.23

Ani pharmaceuticals reports third quarter results.q3 adjusted non-gaap earnings per share $1.23.q3 gaap earnings per share $0.32.q3 revenue $51.3 million versus refinitiv ibes estimate of $56 million.q3 earnings per share estimate $1.43 -- refinitiv ibes data.sees net revenues for fy2019 $209 million to $212 million.sees adjusted non-gaap ebitda for fy2019 $84.7 million to $86.8 million.sees adjusted non-gaap diluted earnings per share for fy2019 $5.06 to $5.23.
ANIP Ratings Summary
ANIP Quant Ranking